The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, neurosensory and functional assessments at 22-26 months corrected age (Infants born prior to July 1, 2012 were seen at 18-22 months corrected age). Data regarding pregnancy and neonatal outcome are collected prospectively. The goal is to identify potential maternal and neonatal risk factors that may affect infant neurodevelopment.
Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature
The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, neurosensory and functional assessments at 22-26 months corrected age (Infants born prior to July 1, 2012 were seen at 18-22 months corrected age). Data regarding pregnancy and neonatal outcome are collected prospectively. The goal is to identify potential maternal and neonatal risk factors that may affect infant neurodevelopment.
Follow-up Visit of High Risk Infants
-
University of Alabama at Birmingham, Birmingham, Alabama, United States, 35233
University of California - Los Angeles, Los Angeles, California, United States, 90025
Stanford University, Palo Alto, California, United States, 94304
University of California at San Diego, San Diego, California, United States, 92103-8774
Sharp Mary Birch Hospital for Women & Newborns, San Diego, California, United States, 92123
Yale University, New Haven, Connecticut, United States, 06504
George Washington University, Washington, District of Columbia, United States, 20052
University of Miami, Miami, Florida, United States, 33136
Emory University, Atlanta, Georgia, United States, 30303
Northwestern Lurie Children's Hospital of Chicago, Chicago, Illinois, United States, 60611
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Months to 26 Months
ALL
No
NICHD Neonatal Research Network,
Abbot R. Laptook, MD, PRINCIPAL_INVESTIGATOR, Brown University, Women & Infants Hospital of Rhode Island
Michele C. Walsh, MD MS, PRINCIPAL_INVESTIGATOR, Case Western Reserve University, Rainbow Babies and Children's Hospital
C. Michael Cotten, MD, MHS, PRINCIPAL_INVESTIGATOR, Duke University
David P. Carlton, MD, PRINCIPAL_INVESTIGATOR, Emory University
Greg M. Sokol, MD, PRINCIPAL_INVESTIGATOR, Indiana University
Abhik Das, PhD, PRINCIPAL_INVESTIGATOR, RTI International
Krisa P. Van Meurs, MD, PRINCIPAL_INVESTIGATOR, Stanford University
Brenda B. Poindexter, MD, PRINCIPAL_INVESTIGATOR, Children's Hospital Medical Center, Cincinnati
Waldemar A. Carlo, MD, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham
Edward F. Bell, MD, PRINCIPAL_INVESTIGATOR, University of Iowa
Kristi L. Watterberg, MD, PRINCIPAL_INVESTIGATOR, University of New Mexico
Myra H. Wyckoff, MD, PRINCIPAL_INVESTIGATOR, University of Texas, Southwestern Medical Center at Dallas
Jon E Tyson, MD, MPH, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston
Bradley A. Yoder, MD, PRINCIPAL_INVESTIGATOR, University of Utah
Seetha Shankaran, MD, PRINCIPAL_INVESTIGATOR, Wayne State University
William E. Truog, MD, PRINCIPAL_INVESTIGATOR, Children's Mercy Hospital Kansas City
Pablo J. Sanchez, MD, PRINCIPAL_INVESTIGATOR, Research Institute at Nationwide Children's Hospital
Uday Devaskar, MD, PRINCIPAL_INVESTIGATOR, University of California, Los Angeles
Carl T D'Angio, MD, PRINCIPAL_INVESTIGATOR, University of Rochester
Eric C Eichenwald, MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania
2030-03-31